• Profile
Close

Isavuconazole as successful salvage therapy for mucormycosis in pediatric patients

The Pediatric Infectious Disease Journal Apr 11, 2020

Ashkenazi-Hoffnung L, Bilavsky E, Levy I, et al. - Researchers investigated the efficacy of Isavuconazole in treatment of children with mucormycosis, a rare but life-threatening fungal disease. The demographic and clinical data of pediatric patients with proven mucormycosis who were treated with isavuconazole in 2015 to 2019 were collected. At 2 centers, four children of (three with underlying hematologic malignancies, and 1 with sustained major trauma; median age: 10.5 years) received isavuconazole as salvage therapy. Complete clinical, radiological and mycological responses were documented in all patients following treatment and surgical intervention. A literature review revealed successful treatment with isavuconazole, as salvage therapy, in majority of 8 children with mucormycosis. Outcomes thereby support isavuconazole as a valuable salvage therapy in pediatric mucormycosis.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay